Why the study?
Thoracic aortic calcifications are common on medical imaging, but their association with major adverse limb events, other cardiovascular outcomes, and mortality in cardiovascular disease patients needed assessment.
Does the presence of thoracic aortic calcifications on chest radiographs predict major adverse limb events in patients with cardiovascular disease?
Does the presence of thoracic aortic calcifications on chest radiographs predict major adverse limb events in patients with cardiovascular disease?
The presence of thoracic aortic calcifications on routine chest radiographs independently predicts a more than twofold increased risk of major adverse limb events in patients with cardiovascular disease.
TAC on radiographs may flag higher MALE and mortality risk in CVD; leaves open added value beyond standard models.
Thoracic aortic calcifications (TAC) are a common finding in medical imaging. We assessed the association between TAC on chest radiographs and major adverse limb events (MALE), other cardiovascular outcomes, and mortality in cardiovascular disease patients. A total of 4680 patients were included from the prospective Utrecht Cardiovascular Cohort-Second Manifestation of ARTerial disease cohort. TAC severity was classified based on chest radiographs by certified readers as mild, moderate, and severe. Multivariate cox proportional hazard models were utilized to assess associations between TAC and incident MALE defined as major amputation, peripheral revascularization or thrombolysis in the lower limb. Secondary endpoints included major adverse cardiovascular events (MACE: stroke, myocardial infarction, and vascular death), and all-cause mortality. A total of 4680 patients were included. TAC was present in 1789 (38%) patients. After a median follow-up of 11.8 years (interquartile range: 7.6–15.7 years), 426 MALE, 992 MACE, and 1387 deaths occurred. TAC presence was associated with incident MALE after adjustments, (hazard ratio (HR):2.14;95%CI:1.73–2.65) and this risk increased with TAC severity (HR mild : 1.97; 95%CI:1.51–2.57, HR moderate : 2.04; 95%CI:1.56–2.68, and HR severe : 2.71; 95%CI: 2.02–3.65). Moreover, TAC was associated with incident MACE (HR:1.22;95%CI:1.06–1.40), ischemic stroke (HR: 1.45; 95%CI: 1.11–1.91), and vascular death (HR: 1.35; 95%CI: 1.13–1.63). TAC was only associated with all-cause mortality (HR:1.34;95%CI:1.18–1.52) in patients who experienced a previous cardiovascular event. In cardiovascular disease patients, TAC on chest radiographs is associated with an increased risk for incident MALE. In addition, we found that TAC was associated with incident ischemic stroke, MACE and all-cause mortality.
No takes yet. Share an insight, caveat, or question.
Harlianto et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: